Health, Fitness & Food

Bernard Tyson, Kaiser Permanente David A. Grogan | CNBC Kaiser Permanente chairman and CEO Bernard Tyson died unexpectedly in his sleep Sunday, the health care giant announced. One of the nation’s leading health care executives, Tyson was 60. He rose through the ranks during a 30-year career at Kaiser to become CEO in 2013. Over
0 Comments
In a recent study, researchers attempt to determine how neighbourhood walkability and cardiovascular risk are related using a Canadian study sample. Cardiovascular disease is a significant cause of mortality worldwide. Exercise can be helpful in lowering the risk of cardiovascular disease, unfortunately, only about one in four Americans participate in regular exercise activities. The negative
0 Comments
Livongo co-founder and executive chairman Glen Tullman speaks at CNBC’s @Work conference in San Francisco, California, on Nov. 4, 2019. CNBC For health-technology start-ups, hiring technical talent from Silicon Valley can be a tricky prospect. Companies like Apple and Facebook are paying massive salaries, making it challenging for any upstart to bring talented workers into
0 Comments
Activists marched to the offices of Senators Schumer and Gillibrand in New York City on September 5, 2017; carrying a giant lunchbox filled with messages from constituents that urged them to get Back To Work and Save Our Healthcare. Erik McGregor | LightRocket | Getty Images Wealthy Americans stand to gain from Obamacare’s demise. The
0 Comments
Harriet Taylor Hardware is increasingly becoming a commodity, where devices with nearly identical features end up competing mainly on price. But for big consumer technology companies like Apple and Google, it’s still important to have a foothold in the wearable devices market because it’s the key way to get information about users on the go,
0 Comments
BY THE NUMBERS U.S. stock futures were pointing to a rebound at Friday’s open ahead of the government’s before-the-bell release of its monthly employment report. Thursday’s losses ended an otherwise positive October, with the S&P 500 and Nasdaq seeing their best monthly gains since June. The Dow lagged and edged higher by just a half-percent.
0 Comments
Biotech firm Biogen could double its market cap on regulatory approval for its experimental Alzheimer’s drug, aducanumab, CNBC’s Jim Cramer said Wednesday. Biogen, with a $54.1 billion market cap as of Wednesday’s close, “could be worth twice that if all goes well” with the Food and Drug Administration, the “Mad Money” host said. In March,
0 Comments
A Johnson & Johnson building is shown in Irvine, California. Mike Blake | Reuters Johnson & Johnson, which recalled 33,000 bottles of baby powder earlier this month, said Monday it retested its baby powder and found no signs of asbestos that prompted the recall. J&J pulled the powder off of shelves after federal regulators said
0 Comments
Researchers conducted a comprehensive review of scientific literature investigating associations between plant- and animal-based diet and prostate cancer risk. Around one in nine Canadian men are diagnosed with prostate cancer at some point in their lifetime. Prostate cancer is one of the most common types of cancer among men. There has been evidence that suggests
0 Comments
Chris Ratcliffe | Bloomberg | Getty Images The number of cases of a deadly lung illness linked to vaping appears to be “leveling off or even declining,” a Centers for Disease Control and Prevention official said Friday. “It’s serious and potentially fatal, but it is preventable,” Dr. Anne Schuchat, the CDC’s principal deputy director, told
0 Comments
The U.S. judicial system will ultimately block a court ruling that questioned the constitutionality of Obamacare, Centene CEO Michael Neidorff told CNBC on Thursday. A federal appeals court in New Orleans is expected to soon hand down a decision on the legality of the Affordable Care Act, the landmark health-care law enacted under President Barack
0 Comments